These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 7107973

  • 1. Assessment of quinidine gluconate for nonlinear kinetics following chronic dosing.
    Russo J, Russo ME, Smith RA, Pershing LK.
    J Clin Pharmacol; 1982; 22(5-6):264-70. PubMed ID: 7107973
    [Abstract] [Full Text] [Related]

  • 2. Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.
    Edwards DJ, Axelson JE, Visco JP, vanEvery S, Slaughter RL, Lalka D.
    Br J Clin Pharmacol; 1987 Mar; 23(3):351-4. PubMed ID: 3567051
    [Abstract] [Full Text] [Related]

  • 3. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA, Taggart WV.
    Clin Ther; 1984 Mar; 7(1):22-7. PubMed ID: 6518461
    [Abstract] [Full Text] [Related]

  • 4. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV, Holyoak W.
    Clin Ther; 1983 Mar; 5(4):357-64. PubMed ID: 6871920
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA, Visco J, Slaughter RL.
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion kinetics of intact quinidine and 3-OH-quinidine after oral administration of a single oral dose of quinidine gluconate in the fasting and non-fasting state.
    St-Onge JM, Sirois G, Gagnon MA.
    Eur J Drug Metab Pharmacokinet; 1983 Feb; 8(4):363-72. PubMed ID: 6673973
    [Abstract] [Full Text] [Related]

  • 10. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC, de Lamirande E, Horning MG, Pang KS.
    Drug Metab Dispos; 1982 Feb; 10(6):568-72. PubMed ID: 6130901
    [Abstract] [Full Text] [Related]

  • 11. Kinetics and electrocardiographic changes after oral 3-OH-quinidine in healthy subjects.
    Vozeh S, Uematsu T, Guentert TW, Ha HR, Follath F.
    Clin Pharmacol Ther; 1985 May; 37(5):575-81. PubMed ID: 3987181
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.
    Jaillon P, Poirier JM, Lecocq B, Jarreau C, Pays M, Richard MO, Cheymol G.
    Eur J Drug Metab Pharmacokinet; 1986 May; 11(3):233-8. PubMed ID: 3816879
    [Abstract] [Full Text] [Related]

  • 13. Comparative quinidine plasma profiles at steady state of two controlled-release products and quinidine sulfate in solution.
    Wright GJ, Melikian AP, Pitts JE, Crowe JT, Morley EM.
    Biopharm Drug Dispos; 1987 May; 8(2):159-72. PubMed ID: 3593896
    [Abstract] [Full Text] [Related]

  • 14. Relative bioavailability of quinidine gluconate and quinidine sulfate in healthy volunteers.
    Covinsky JO, Russo J, Kelly KL, Cashman J, Amick EN, Mason WD.
    J Clin Pharmacol; 1979 May; 19(5-6):261-9. PubMed ID: 469022
    [Abstract] [Full Text] [Related]

  • 15. Serious bioavailability problems with a generic prolonged-release quinidine gluconate product.
    Meyer MC, Straughn AB, Lieberman P, Jacob J.
    J Clin Pharmacol; 1982 May; 22(2-3):131-4. PubMed ID: 7068936
    [Abstract] [Full Text] [Related]

  • 16. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
    Camsonne R, Moulin MA, Charbonneau P, Bazin C.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
    [Abstract] [Full Text] [Related]

  • 17. Kinetics and dynamics of quinidine-N-oxide in healthy subjects.
    Ha HR, Vozeh S, Uematsu T, Guentert TW, Follath F.
    Clin Pharmacol Ther; 1987 Sep; 42(3):341-5. PubMed ID: 3621790
    [Abstract] [Full Text] [Related]

  • 18. Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokinetics.
    Bottorff MB, Lalonde RL, Straughn AB.
    Biopharm Drug Dispos; 1987 Sep; 8(3):213-21. PubMed ID: 3297181
    [Abstract] [Full Text] [Related]

  • 19. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT, Williamson BJ, Dzindzio BS.
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of quinidine and three of its metabolites in man.
    Rakhit A, Holford NH, Guentert TW, Maloney K, Riegelman S.
    J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.